Category: Generics Drugs
Global Generics Drugs
-
Pharmaceutical Intermediates Global Market Opportunities And Strategies To 2033
... Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Musculoskeletal Disorders Drugs; Metabolic Disorders Drugs4) By End-User: Biotech And Pharma Companies; Research InstitutionsCovering: BASF SE; Evonik Industries AG; Pfizer Inc.; Arkema Inc.; Koninklijke DSM N.V. Pharmaceutical Intermediates Global ... Read More
-
Global Generic drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
2024 Global: Branded Generics - Innovative Markets Forecast (2030) report
... 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression analysis in ... Read More
-
Gastrointestinal Diseases Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Anti-inflammatory and immunosuppressors, Acid neutralizers, Others), By Type (Branded, Generics), by Region, Country, Segment, and Companies, 2024-2030
... size is poised to register 5.05% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gastrointestinal Diseases Therapeutics market By Drug Class ... Read More
-
Branded Generics Market Size, Trends, Analysis, and Outlook By Drug Class (Alkylating Agents, Antimetabolites, Hormones, Anti-Hypertensive, Lipid Lowering Drugs, Anti-Depressants, Anti-Psychotics, Anti-Epileptics, Others), By Application (Oncology, Cardiovascular Diseases, Neurological Diseases, Gastrointestinal Diseases, Dermatological Diseases, Acute and Chronic Pain, Others), By Route of Administration (Topical, Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... and Chronic Pain, Others), By Route of Administration (Topical, Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Branded Generics market size is ... Read More
-
Gastrointestinal Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Gastrointestinal Therapeutics market size is poised to register ... Read More
-
Antibiotics Market Size, Trends, Analysis, and Outlook By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenems, Aminoglycosides, Sulfonamides, 7-ACA, Others), By Type (Branded Antibiotics, Generic Antibiotics), By Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antibiotics market size is poised to register 4.79% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Opioid-Induced Constipation Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Drug Class (Aminosalicylates, Digestive enzymes, Proton Pump Inhibitors, Laxatives, Anti-Emetics, H2 Antagonists, Anti-Diarrheal, Biologics/Biosimilar, Others), By Route of Administration (Oral, Injectable, Others), By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... By Application (Crohn's disease, Ulcerative colitis, GERD, IBS, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Opioid-Induced Constipation market size is poised to register ... Read More
-
OTC Dry Eye Drops Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Product (With Preservatives, Preservative Free), By Viscosity (Low Viscosity, High Viscosity), By Distribution Channel (Drugstores and Supermarkets, Online Pharmacies, Retail Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030
... Pharmacies, Others), by Region, Country, Segment, and Companies, 2024-2030 The global OTC Dry Eye Drops market size is poised to register 7.67% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Pharmaceutical CDMO Market Size, Trends, Analysis, and Outlook By Product (API), By Synthetic, Solid, Liquid), By Type (Traditional API, Highly Potent API, Antibody Drug Conjugate (ADC), Others), By Drug (Innovative, Generics), By Manufacturing (Continuous manufacturing, Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030
... Batch manufacturing, Biotech, Drug Product, Oral solid dose, Semi-solid dose, Liquid dose, Others), By WorkFlow (Clinical, Commercial), By Application (Oncology, Hormonal, Glaucoma, Cardiovascular disease, Diabetes, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Generic Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Geriatric Population and Cost Affordability of Generic Drugs Projected ... Read More
-
Ophthalmic Drugs Market Size, Trends, Analysis, and Outlook By Class (Anti-allergy, Steroidal drugs, Anti-VEGF Agents, Anti-glaucoma, Others), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis, Others), By Dosage Form (Gels, Eye, Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), By Product Type (Prescription Drugs, OTC Drugs), By Product (Branded Drugs, Generic Drugs), by Region, Country, Segment, and Companies, 2024-2030
... Suspensions, Capsules and Tablets, Eye Drops, Ointments, Others), By Route of Administration (Topical, Local Ocular(Retinal Disorders, Subconjunctival, Intravitreal, Retrobulbar, Intracameral), Systemic), By Dosage Type (Gels, Eye Solutions & Suspensions, Capsules and Tablets, Eye Drops, Ointments), ... Read More
-
Generic Pharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Drug (Branded Generics, Unbranded Generics), By Product (API, Drug Product), By Route of Administration (Oral, Parenteral, Topical, Others), By Application (Oncology, Immunology, Antidiabetic, Neurology, Anticoagulants, Cardiovascular, Respiratory, Pain, HIV Antivirals, Others), by Region, Country, Segment, and Companies, 2024-2030
... Anticoagulants, Cardiovascular, Respiratory, Pain, HIV Antivirals, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals Contract Manufacturing market size is poised to register 6.62% growth from 2024 to 2030, presenting significant growth ... Read More
-
Myelodysplastic Syndrome Drugs Market Size, Trends, Analysis, and Outlook By Therapeutic Class (Hypomethylating Agents, Immunomodulatory Drugs, Anti-Anemics), By Type Of Syndrome (Refractory Cytopenia With Multilineage Dysplasia, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Application (Original, Generics), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030
... With Ringed Sideroblasts), By Route of Administration (Oral, Parenteral), By Application (Original, Generics), By End-user (Hospitals, Clinics, Ambulatory Surgical Centers), by Region, Country, Segment, and Companies, 2024-2030 The global Myelodysplastic Syndrome Drugs market size is ... Read More
-
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030
... Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Antiviral Drugs market size is poised to register 4.55% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
Pulmonary Arterial Hypertension Market Size, Trends, Analysis, and Outlook By Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors. Prostacyclin and Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Pulmonary Arterial Hypertension market size is poised to register 5.93% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
The 2025-2030 World Outlook for Cold-Chain Generic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Influenza Medications
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Generic Injectables
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Generics in Antivirals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Prescription Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Generic Oncology Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
